Immunological detection of the type v collagen propeptide fragment, PVCP-1230, in connective tissue remodeling associated with liver fibrosis

Biomarkers

Volumn 16, Issue 5, 2011, Pages 426-433

  Vassiliadis, Efstathios ^a,c   Veidal, Sanne S ^a,c   Simonsen, Henrik ^a   Larsen, Dorthe V ^a   Vainer, Ben ^d   Chen, Xiaoliang ^b   Zheng, Qinlong ^b   Karsdal, Morten A ^a,c   Leeming, Diana J ^a  

^a NORDIC BIOSCIENCE A S   (Denmark)

^b Nordic Bioscience Beijing   (China)

^c UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^d Rigshospitalet   (Denmark)

Author keywords

Bile duct ligation; Biochemical markers; Carbon tetrachloride; Liver fibrosis; N terminal; Propeptide; Type V collagen

Indexed keywords

BIOTIN; CARBON TETRACHLORIDE; COLLAGEN TYPE 5; MONOCLONAL ANTIBODY; PROTEIN CO5 1230; STREPTAVIDIN; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BILE DUCT LIGATION; CARBOXY TERMINAL SEQUENCE; CONNECTIVE TISSUE; CONTROLLED STUDY; CORRELATION COEFFICIENT; ENZYME LINKED IMMUNOSORBENT ASSAY; EXTRACELLULAR MATRIX; IMMUNOASSAY; LIVER FIBROSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; QUANTITATIVE ANALYSIS; RAT; SEQUENCE ANALYSIS;

ANIMALS; COLLAGEN TYPE V; CONNECTIVE TISSUE; ENZYME-LINKED IMMUNOSORBENT ASSAY; LIVER CIRRHOSIS; MALE; MICE; MICE, INBRED BALB C; PEPTIDE FRAGMENTS; RATS; RATS, WISTAR; REPRODUCIBILITY OF RESULTS;

RATTUS;

EID: 79960788301     PISSN: 1354750X     EISSN: 13665804     Source Type: Journal    
DOI: 10.3109/1354750X.2011.584131     Document Type: Article

References (25)

1. Bagger YZ, Tanko LB, Alexandersen P, Karsdal MA, Olson M, Mindeholm L, Azria M, Christiansen C. (2005). Oral salmon calcitonin induced suppression of urinary collagen type II degradation in postmenopausal women: a new potential treatment of osteoarthritis. Bone 37:425-430. (Pubitemid 41160502)
2. Barascuk N, Veidal SS, Larsen L, Larsen DV, Larsen MR, Wang J, Zheng Q, Xing R, Cao Y, Rasmussen LM, Karsdal MA. (2010). A novel assay for extracellular matrix remodeling associated with liver fbrosis: an enzyme-linked immunosorbent assay (ELISA) for a MMP-9 proteolytically revealed neo-epitope of type III collagen. Clin Biochem 43:899-904.
3. Braun RK, Martin A, Shah S, Iwashima M, Medina M, Byrne K, Sethupathi P, Wigfeld CH, Brand DD, Love RB. (2010). Inhibition of bleomycin-induced pulmonary fbrosis through pre-treatment with collagen type V. J Heart Lung Transplant 29:873-880.
4. Breuls RGM, Klumpers DD, Everts V, Smit TH. (2009). Collagen type V modulates fbroblast behaviour dependent on substrate stifness. Biochem Biophys Res Commun 380:425-429.
5. Clarià J, Jimenez W. (1999). Renal dysfunction and ascites in carbon tetrachloride-induced cirrhosis in rats. In The Liver and the Kidney, Arroyo V et al., eds. Blackwell Science, Boston, pp. 379-396.
6. Combet C, Blanchet C, Geourjon C, Deléage G. (2000). NPS@: network protein sequence analysis. Trends Biochem Sci 25:147-150. (Pubitemid 30122428)
7. Copple BL, Allen K, Welch TP. (2010). Mechanisms of liver fbrosis. Compr Toxicol 9:263-274.
8. Fichard A, Kleman JP, Ruggiero F. (1995). Another look at collagen V and XI molecules. Matrix Biol 14:515-531.
9. Friedman SL. (2003). Liver fbrosis-from bench to bedside. J Hepatol 38 (Suppl 1):S38-S53.
10. Garnero P, Ferreras M, Karsdal MA, Nicamhlaoibh R, Risteli J, Borel O, Qvist P, Delmas PD, Foged NT, Delaissé JM. (2003). The type I collagen fragments ICTP and CTX reveal distinct enzymatic pathways of bone collagen degradation. J Bone Miner Res 18:859-867. (Pubitemid 37294969)
11. Gefter ML, Margulies DH, Scharf MD. (1977). A simple method for polyethylene glycol-promoted hybridization of mouse myeloma cells. Somatic Cell Genet 3:231-236. (Pubitemid 8133604)
12. Gelse K, Pöschl E, Aigner T. (2003). Collagens-structure, function, and biosynthesis. Adv Drug Deliv Rev 55:1531-1546.
13. Gressner OA, Weiskirchen R, Gressner AM. (2007). Biomarkers of liver fbrosis: clinical translation of molecular pathogenesis or based on liver-dependent malfunction tests. Clin Chim Acta 381:107-113. (Pubitemid 46719142)
14. Karsdal MA, Henriksen K, Leeming DJ, Mitchell P, Dufn K, Barascuk N, Klickstein L, Aggarwal P, Nemirovskiy O, Byrjalsen I, Qvist P, Bay-Jensen AC, Dam EB, Madsen SH, Christiansen C. (2009). Biochemical markers and the FDA Critical Path: how biomarkers may contribute to the understanding of pathophysiology and provide unique and necessary tools for drug development. Biomarkers 14:181-202.
15. Muñoz-Luque J, Ros J, Fernández-Varo G, Tugues S, Morales-Ruiz M, Alvarez CE, Friedman SL, Arroyo V, Jiménez W. (2008). Regression of fbrosis after chronic stimulation of cannabinoid CB2 receptor in cirrhotic rats. J Pharmacol Exp Ter 324:475-483. (Pubitemid 351185849)
16. Osawa Y, Seki E, Adachi M, Taura K, Kodama Y, Siegmund SV, Schwabe RF, Brenner DA. (2006). Systemic mediators induce fbrogenic efects in normal liver after partial bile duct ligation. Liver Int 26:1138-1147. (Pubitemid 44541755)
17. Ruggiero F, Champliaud MF, Garrone R, Aumailley M. (1994). Interactions between cells and collagen V molecules or single chains involve distinct mechanisms. Exp Cell Res 210:215-223. (Pubitemid 24168518)
18. Schuppan D, Ruehl M, Somasundaram R, Hahn EG. (2001). Matrix as a modulator of hepatic fbrogenesis. Semin Liver Dis 21:351-372.
19. Segovia-Silvestre T, Reichenbach V, Ros J, Vassiliadis E, Barascuk N, Morales-Ruiz M, Karsdal MA, Jiménez W. (2010). CO3-610, a novel non-invasive serum marker of liver fbrosis and portal hypertension in carbon tetrachloride-treated rats. In review.
20. Tsukadaa S, Parsonsb CJ, Rippe RA. (2006). Mechanisms of liver fbrosis. Clin Chim Acta 364:33-60.
21. Tugues S, Fernandez-Varo G, Muñoz-Luque J, Ros J, Arroyo V, Rodés J, Friedman SL, Carmeliet P, Jiménez W, Morales-Ruiz M. (2007). Antiangiogenic treatment with sunitinib ameliorates infammatory infltrate, fbrosis, and portal pressure in cirrhotic rats. Hepatology 46:1919-1926.
22. Veidal SS, Bay-Jensen A-C, Tougas G, Karsdal MA, Vainer B. (2010). Serum markers of liver fbrosis: combining the BIPED classifcation and the neo-epitope approach in the development of new biomarkers. Dis Markers 28:15-28.
23. Veidal SS, Vassiliadis E, Bay-Jensen AC, Tougas G, Vainer B, Karsdal MA. (2010). Procollagen type I N-terminal propeptide (PINP) is a marker for fbrogenesis in bile duct ligation-induced fbrosis in rats. Fibrogenesis Tissue Repair 3:5.
24. Weiler-Normann C, Herkel J, Lohse AW. (2007). Mouse models of liver fbrosis. Z Gastroenterol 45:43-50.
25. Wynn TA. (2008). Cellular and molecular mechanisms of fbrosis. J Pathol 214:199-210.